Select Issuer Clients

Select Issuer Clients

Issuer Client Profile

Helocyte, Inc.

Helocyte, Inc. (“Helocyte”), a portfolio company of Fortress Biotech, Inc., is focused on the development and commercialization of novel immunotherapies for the prevention and treatment of cancer and infectious disease (in particular, cytomegalovirus or “CMV”).

View Website

Issuer Client News Feed

For Investors

Want to take part in the next big idea?

Join Our Network

For Entrepreneurs

Want to explore how we add value?

Submit Your Business Plan